Latest News and Press Releases
Want to stay updated on the latest news?
-
ACTG Presents Data from Mpox Study STOMP at CROI
-
Africa CDC’s support for the MOSA has enabled the enrollment of the first patients at Mbandaka Hospital in Equateur Province, Democratic Republic of Congo.
-
JUPITER, Fla., Nov. 21, 2024 (GLOBE NEWSWIRE) -- Dyadic International, Inc. (NASDAQ: DYAI), a global biotechnology company, announced today that it has been awarded a $3 million grant from the Gates...
-
GAITHERSBURG, Md., Sept. 25, 2024 (GLOBE NEWSWIRE) -- Emergent BioSolutions Inc. (NYSE: EBS) today announced it has secured approximately $400 million in orders in 2024 and 2025 associated with its...
-
DURBAN, South Africa, Sept. 18, 2024 (GLOBE NEWSWIRE) -- The Global Virus Network concluded its annual meeting of closed scientific sessions held 16-18 September 2024 with a press conference....
-
TAMPA, Fla., Sept. 02, 2024 (GLOBE NEWSWIRE) -- A correction has been issued for the release disseminated on August 16th. Sten Vermund's full title was corrected to Sten Vermund, MD, PhD, GVN...
-
Last week’s meeting marked a prelude to GVN’s international meeting in Durban, South Africa, September 16-18, 2024 TAMPA, Fla., Aug. 31, 2024 (GLOBE NEWSWIRE) -- A correction has been issued for...
-
GAITHERSBURG, Md., Aug. 29, 2024 (GLOBE NEWSWIRE) -- Emergent BioSolutions Inc. (NYSE: EBS) today announced that the U.S. Food and Drug Administration (FDA) has approved the supplemental Biologics...
-
Last week’s meeting marked a prelude to GVN’s international meeting in Durban, South Africa, September 16-18, 2024TAMPA, Fla., Aug. 29, 2024 (GLOBE NEWSWIRE) -- To mitigate the mpox outbreak,...
-
Company to Provide a Detailed Overview of Mpox Including Commentary on the Rapid Spread and Methods for Control, Treatment, and Prevention ATLANTA, GA, Aug. 21, 2024 (GLOBE NEWSWIRE) -- GeoVax...